Synapse Open Synapse
Biology

When AI designs a drug, who gets the credit?

MIT TR Biotechnology · · 4 min read

When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform.

Latest from MIT TR Biotechnology